Tocqueville Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-20,925
Closed -$819K 809
2018
Q4
$819K Sell
20,925
-4,100
-16% -$178K 0.01% 486
2018
Q3
$1.36M Sell
25,025
-16,200
-39% -$1.11M 0.02% 458
2018
Q2
$3.41M Buy
41,225
+1,075
+3% +$83K 0.04% 367
2018
Q1
$2.67M Sell
40,150
-2,000
-5% -$115K 0.03% 399
2017
Q4
$2.17M Sell
42,150
-1,700
-4% -$122K 0.02% 430
2017
Q3
$3.91M Sell
43,850
-1,500
-3% -$114K 0.05% 359
2017
Q2
$2.71M Sell
45,350
-14,500
-24% -$810K 0.03% 385
2017
Q1
$3.19M Buy
59,850
+5,500
+10% +$327K 0.04% 360
2016
Q4
$2.71M Buy
54,350
+7,200
+15% +$386K 0.03% 369
2016
Q3
$2.83M Sell
47,150
-3,500
-7% -$202K 0.03% 366
2016
Q2
$2.59M Buy
50,650
+2,000
+4% +$85.5K 0.03% 374
2016
Q1
$1.44M Buy
48,650
+4,325
+10% +$136K 0.02% 442
2015
Q4
$2.01M Buy
44,325
+6,100
+16% +$320K 0.03% 422
2015
Q3
$1.59M Buy
38,225
+34,225
+856% +$1.79M 0.02% 479
2015
Q2
$241K Buy
+4,000
New +$264K ﹤0.01% 890

Other funds holding ONCE

Tocqueville Asset Management's ONCE Position: Q1 2019 in Review

Tocqueville Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 20,925 shares — an estimated $819K sold.

Tocqueville Asset Management first reported a position in ONCE in Q2 2015 and held it in 15 quarters. The position peaked at $3.91M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Tocqueville Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 20,925 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $819K.
  • Tocqueville Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 15 quarters.
  • Tocqueville Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $3.91M in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Tocqueville Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.